Sponsor or institution
Clinical trials and research at Seoul St. Mary's Hospital
As of November 12, 2026, Find a Trial lists 7 clinical trials run by Seoul St. Mary's Hospital that are recruiting, in South Korea. By phase: Phase 2 (2), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Predicting Atrial Fibrillation with a Genetic Risk Score | — | Incheon and 4 other locations | Recruiting | Jun 11, 2026 |
| Enavogliflozin for Amyloid Cardiomyopathy | Phase 4 | Seoul and 1 other locations | Recruiting | Nov 21, 2025 |
| Quality of life and treatment outcomes for relapsed/refractory multiple myeloma with advanced versus conventional immunotherapies. | — | Seocho, Seoul | Recruiting | Jul 4, 2025 |
| Comparing advanced and classical immunotherapy for lymphoma treatment | — | Seoul and 1 other locations | Recruiting | Jan 28, 2025 |
| Comparing Ruxolitinib with Steroids for Chronic Graft-versus-Host Disease Treatment | Phase 2 | Seoul, Banpo-daero/Seocho-gu | Recruiting | Jan 1, 2025 |
| Treatment for high-risk pediatric leukemia | Phase 2 | Seoul, Seoul and 8 other locations | Recruiting | Dec 28, 2023 |
| Effects of SGLT2 inhibitors on heart health in type 2 diabetes patients after heart attacks | — | Seoul | Recruiting | Mar 15, 2023 |
All recruiting trials (7)
-
Predicting Atrial Fibrillation with a Genetic Risk Score
Researchers test whether a polygenic risk score can help flag people likely to have undiagnosed atrial fibrillation, alongside at-home and clinic heart monitoring.
-
Enavogliflozin for Amyloid Cardiomyopathy
This study tests whether Enavogliflozin helps people with amyloid cardiomyopathy and heart failure by comparing it to placebo in two treatment periods.
-
Quality of life and treatment outcomes for relapsed/refractory multiple myeloma with advanced versus conventional immunotherapies.
This will test whether advanced immuno-oncology treatments lead to different quality of life, safety, and treatment outcomes than conventional immunotherapies in adults with relapsed or refractory multiple myeloma.
-
Comparing advanced and classical immunotherapy for lymphoma treatment
This study is testing whether newer immunotherapy treatments for high-grade B cell lymphoma work better and are safer than traditional methods for adults who have already had treatment that didn't work.
-
Comparing Ruxolitinib with Steroids for Chronic Graft-versus-Host Disease Treatment
This study is testing if a new treatment combining Ruxolitinib with steroids can help people with moderate to severe chronic graft-versus-host disease feel better compared to just using steroids alone.
-
Treatment for high-risk pediatric leukemia
This study is testing a personalized chemotherapy plan for children with high-risk leukemia to see if it can improve their treatment outcomes based on their disease levels.
-
Effects of SGLT2 inhibitors on heart health in type 2 diabetes patients after heart attacks
This study is testing if a diabetes medication called SGLT2 inhibitors can help improve heart health and reduce heart problems in people with type 2 diabetes who have had a heart attack.
Quick answers
How many clinical trials run by Seoul St. Mary's Hospital are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.